Noxaban

诺克沙班

Report date: 2022/12/29 15:52:03
NME

Base Information

Drug NameNoxaban
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsVenous ThromboembolismLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhaoke Pharmaceutical (Guangzhou) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhaoke Pharmaceutical (Guangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsVenous ThromboembolismLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A